Skip to main content

Annals of Hematology

Ausgabe 10/2013

Inhalt (22 Artikel)

Review Article

Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice

Nayoun Kim, Keon-Il Im, Jung-Yeon Lim, Eun-Joo Jeon, Young-Sun Nam, Eun-Jung Kim, Seok-Goo Cho

Original Article

De novo AML patients with favourable–intermediate karyotype may benefit from the addition of low-dose gemtuzumab ozogamicin (GO) to fludarabine, Ara-C and idarubicin (FLAI): a contribution to the reopened “GO question”

Marino Clavio, Fabio Cruciani, Paola Minetto, Fabio Guolo, Filippo Ballerini, Carlo Marani, Enrico De Astis, Sara Aquino, Micaela Bergamaschi, Laura Mitscheunig, Raffaella Grasso, Nicoletta Colombo, Chiara Ghiggi, Davide Lovera, Giordana Pastori, Daniele Avenoso, Maurizio Miglino, Marco Gobbi

Original Article

Rapid detection of IDH2 (R140Q and R172K) mutations in acute myeloid leukemia

Saquib Ashraf, Nélida I. Noguera, Jonny Di Giandomenico, Serena Zaza, Syed Khizer Hasan, Francesco Lo-Coco

Original Article

Centrosome aberrations in bone marrow cells from patients with myelodysplastic syndromes correlate with chromosomal instability

Florian Nolte, Michelle Giehl, Wiltrud Haass, Verena Nowak, Christiane Schumann, Daniel Nowak, Maximillian Mossner, Henning D. Popp, Torsten J. Schulze, Stefan Klein, Wolfgang Seifarth, Wolf-Karsten Hofmann, Alice Fabarius

Original Article

The clinical importance of moderate/severe bone marrow fibrosis in patients with therapy-related myelodysplastic syndromes

Bin Fu, Chi Young Ok, Maitrayee Goswami, Wei Xei, Jesse M. Jaso, Tariq Muzzafar, Carlos Bueso-Ramos, Srdan Verstovsek, Guillermo Garcia-Manero, L. Jeffrey Medeiros, Sa A. Wang

Original Article

Improved tolerability by a modified intermittent treatment schedule of dasatinib for patients with chronic myeloid leukemia resistant or intolerant to imatinib

Paul La Rosée, Philippe Martiat, Armin Leitner, Thomas Klag, Martin C. Müller, Philipp Erben, Thomas Schenk, Susanne Saussele, Andreas Hochhaus

Original Article

Activation of the PI3K/AKT/mTOR pathway in diffuse large B cell lymphoma: clinical significance and inhibitory effect of rituximab

Zi-Zhen Xu, Zu-Guang Xia, Ai-Hua Wang, Wen-Fang Wang, Zhi-Yin Liu, Li-Yun Chen, Jun-Min Li

Original Article

Assessing DcR3 expression in relation to survivin and other prognostic factors in B cell non-Hodgkin’s lymphoma

Ahmed M. L. Bedewy, Maha M. Adel Elgammal, Magdy M. L. Bedewy, Shereen M. EL-Maghraby

Original Article

The role of 18F-fluorodeoxyglucose positron emission tomography at response assessment after autologous stem cell transplantation in T-cell non-Hodgkin’s lymphoma patients

Byeong Seok Sohn, Dok Hyun Yoon, Kyu Pyo Kim, Shin Kim, Kyung Min Lee, Jung Sun Park, Dae Ho Lee, Jin-Sook Ryu, Jooryung Huh, Il Ki Hong, Cheolwon Suh

Original Article

Feasibility of clofarabine cytoreduction followed by haploidentical hematopoietic stem cell transplantation in patients with relapsed or refractory advanced acute leukemia

Johanna Tischer, Hans Joachim Stemmler, Nicole Engel, Max Hubmann, Susanne Fritsch, Dusan Prevalsek, Christoph Schulz, Anna K. Zoellner, Veit Bücklein, Wolfgang Hill, Georg Ledderose, Andreas Hausmann

Original Article

Allogeneic hematopoietic cell transplantation with reduced-intensity conditioning following FLAMSA for primary refractory or relapsed acute myeloid leukemia

Dominik Schneidawind, Birgit Federmann, Christoph Faul, Wichard Vogel, Lothar Kanz, Wolfgang Andreas Bethge

Original Article

Combination of fludarabine, amsacrine, and cytarabine followed by reduced-intensity conditioning and allogeneic hematopoietic stem cell transplantation in patients with high-risk acute myeloid leukemia

Marta Krejci, Michael Doubek, Jaroslav Dusek, Yvona Brychtova, Zdenek Racil, Milan Navratil, Miroslav Tomiska, Ondrej Horky, Sarka Pospisilova, Jiri Mayer

Letter to the Editor

Azacitidine as salvage therapy in elderly patients with relapsed acute myeloid leukemia after autologous transplantation

Massimo Breccia, Adriano Salaroli, Alessandra Serrao, Giuliana Alimena

Letter to the Editor

A case of late onset erythropoietic protoporphyria associated with myelodysplastic syndrome treated by the combination of beta carotene and azacitidine

Yoshitaka Nishikawa, Shinya Okuda, Chiaki Takebayashi, Tetsuya Tanimoto, Masahiro Kami, Kazuhiko Kobayashi

Letter to the Editor

Acute vesiculobullous hand dermatitis and anagen effluvium in Ganoderma lucidum-induced aplastic crisis

Min Ju Choi, Do-Young Kim, Jin Seok Kim, Hyunki Kim, Sung Bin Cho

Letter to the Editor

Disseminated plasmacytomas in multiple myeloma: atypical presentations on multimodality images, emphasized on PET/CT

Jingwei Yi, Shengjun Wang, Shirong Ma, Zhiyong Quan, Xiaohu Zhao, Zhiping Yang, Jing Wang

Letter to the Editor

Pure red cell aplasia associated with CD20+ myeloma: complete remission with rituximab

Chi-Chiu So, William W. L. Choi, Yok-Lam Kwong

Letter to the Editor

Necrotic and ulcerated cutaneous and mucosal leukemia cutis in AML6

Claude Bachmeyer, Marc Buffet, Philippe Moguelet, Albert Najman, Sélim Aractingi

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.